Editorial: The use of dopamine agonist in the treatment of restless legs syndrome: Caution for practitioners and bipolar patients

Southern Medical Journal

Volumn 101, Issue 8, 2008, Pages 785-

  Buckner, Adrian C ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DOPAMINE RECEPTOR STIMULATING AGENT; OPIATE;

AGITATION; ANTICONVULSANT THERAPY; BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DRUG ABUSE; DRUG SAFETY; EDITORIAL; GENERAL PRACTITIONER; HUMAN; MENTAL INSTABILITY; MENTAL PATIENT; OPIATE ADDICTION; PSYCHOSIS; RESTLESS LEGS SYNDROME; SIDE EFFECT; SUICIDE; SUICIDE ATTEMPT; PSYCHOLOGICAL ASPECT;

BIPOLAR DISORDER; DOPAMINE AGONISTS; HUMANS; RESTLESS LEGS SYNDROME;

EID: 65249105967     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31817c6bb4     Document Type: Editorial

References (9)

1. Ball E, Caivano CK. Internal medicine: guidance to the diagnosis and management of restless legs syndrome. South Med J 2008;101(6):631- 634.
2. Muzina DJ. Bipolar spectrum disorder: differential diagnosis and treatment. Prim Care 2007;34:521-550, vi.
3. Lesser IM, Leuchter AF, Trivedi MH, et al. Insured and non-insured depressed outpatients: how do they compare? Ann Clin Psychiatry 2007; 19:73-82.
4. Lader M. Pharmacotherapy of mood disorders and treatment discontinuation. Drugs 2007;67:1657-1663.
5. Elliott RL. Depression in primary care. Ethn Dis 2007;17(2 suppl 2): S2-28-S2-33.
6. Gonda X, Fountoulakis KN, Kaprinis G, et al. Prediction and prevention of suicide in patients with unipolar depression and anxiety. Ann Gen Psychiatry 2007;6:23.
7. Miklowitz DJ, Johnson SL. The psychopathology and treatment of bipolar disorder. Annu Rev Clin Psychol 2006;2:199-235. Review.
8. Berk M, Dodd S, Kauer-Sant'anna M, et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 2007;434:41-49.
9. Clark RE, Samnaliev M, McGovern MP. Treatment for co-occurring mental and substance use disorders in five state Medicaid programs. Psychiatr Serv 2007;58:942-948.